Skip to main navigation
Axsome Corporate Homepage
  • About Axsome
      About Axsome
    • All
    • Overview
    • Management Team
    • Board of Directors
    • Intellectual Property
    • State Disclosures
  • Portfolio
      Portfolio
    • All
    • Products Overview  down arrow
        Products Overview
      • All
      • Overview
      • Sunosi® (solriamfetol)
    • Pipeline Overview  down arrow
        Pipeline Overview
      • All
      • Overview
      • AXS-05
      • AXS-07
      • AXS-12
      • AXS-14
  • Conditions
      Conditions
    • All
    • Overview
    • Depression
    • Migraine
    • Alzheimer’s
      Disease Agitation
    • Excessive Daytime
      Sleepiness
    • Narcolepsy
    • Fibromyalgia
    • Smoking Cessation
  • Axsome Corporate Homepage
  • Science
      Science
    • All
    • Overview
    • Medical Information U.S.
    • Medical Information International
    • Publications
  • Investors
      Investors
    • All
    • Overview
    • Corporate Governance
    • Stock Information
    • Financial Information
    • News & Events
    • Webcasts &
      Presentations
    • Analyst Coverage
    • Shareholder Services
  • Careers
      Careers
    • All
    • Overview
    • Current Opportunities

Committee Composition

Committee Composition

Committee Composition

Documents & Charters Management Team Board of Directors Committee Composition

Below is a summary of our committee structure and membership information. To read more about any of the committees, click on committee names in the chart below.

 

Audit Committee Compensation Committee Nominating and Corporate Governance Committee
Roger Jeffs, PhD Audit Committee Compensation Committee Nominating and Corporate Governance Committee
Mark Saad Audit Committee Compensation Committee Nominating and Corporate Governance Committee
Mark Coleman, MD Audit Committee Compensation Committee Nominating and Corporate Governance Committee
= Chairperson = Member = Financial Expert
  • About Axsome
    • All
    • Overview
    • Management Team
    • Board of Directors
    • Intellectual Property
    • State Disclosures
  • Portfolio
    • All
    • Products Overview
    • Products Overview
    • Auvelity™ (dextromethorphan-bupropion)
    • Sunosi® (solriamfetol)
    • Pipeline Overview
    • AXS‑05
    • AXS‑07
    • AXS‑12
    • AXS‑14
  • Conditions
    • All
    • Overview
    • Depression
    • Migraine
    • Alzheimer's
      Disease Agitation
    • Excessive Daytime
      Sleepiness
    • Narcolepsy
    • Fibromyalgia
    • Smoking Cessation
  • Science
    • All
    • Overview
    • Medical Information U.S.
    • Medical Information International
    • Publications
  • Investors
    • All
    • Overview
    • Corporate Governance
    • Stock Information
    • Financial Information
    • News & Events
    • Webcasts &
      Presentations
    • Analyst Coverage
    • Shareholder Services
  • Careers
    • All
    • Careers
    • Current Opportunities
Axsome
  • Contact Us
  • Privacy Notice
  • Terms of Use
  • See Axsome Therapeutics on Twitter
  • See Axsome Therapeutics on LinkedIn

© 2023 Axsome Therapeutics, Inc. All rights reserved. 22 Cortlandt St, 16th Floor, New York, NY 10007 info@axsome.com